Recently named one of Mayo Clinic’s Top 10 Healthcare Innovations, King-Devick technologies quickly adapted their broad set of objective and evidence-based assessment tools to be compatible with telehealth and remote learning making their web and mobile applications widely accessible to users online. As a result, healthcare providers, patients, educators, and students can maintain continuity of care with King-Devick products even with offices and schools closed during the COVID-19 crisis.
Because of COVID 19, healthcare consultations and testing rapidly adjusted to a new normal with the inclusion of evaluating patients remotely as insurance and Medicare reimbursement procedures were deregulated to include telehealth consultations. Even as doctors’ offices prepare for reopening, the ease and efficiency of integrating King-Devick applications remotely has permanently altered traditional use of the technology to include telehealth administration.
For educators, although the timeline for returning to the classroom is uncertain, the need to broadly assess students who may have fallen behind in reading and enact appropriate remote interventions will be critical to attempt to close the widening learning gap which is a result of schools being closed. The King-Devick Reading Acceleration Program is a remote learning software which will be an important tool in closing that gap.
King-Devick products have been scientifically validated in more than 175 recent peer reviewed articles published in elite medical journals related to concussion management, migraine headaches, macular degeneration, Alzheimer’s disease, hypoxia, multiple sclerosis, Parkinson’s disease and other neurological conditions in addition to reading acceleration. In 2015, Mayo Clinic and King-Devick Test announced a licensing/equity agreement for the King-Devick sideline concussion test – now recognized as the King-Devick Test in association with Mayo Clinic.
